Delivery Order SPE2DB20D2014-SPE2DB25FA87Q

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of REPATHA 140 MG/ML SURECLICK medical products. The $1,179.24 firm fixed-price delivery order has an ultimate completion date of October 28, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,402.64, is a Firm Fixed Price Delivery Order for the supply of REPATHA 140 MG/ML SURECLICK medication. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This federal contract award is a Delivery Order valued at $3,277.96 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of REPATHA 140 MG/ML SURECLICKML, a medication, with a completion date of November 22, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award, valued at $1,402.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of REPATHA 140 MG/ML SURECLICKML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,588.72 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of April 18, 2023 and was not set aside for any special category of businesses. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $7,308.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of REPATHA 140 MG/ML SURECLICKML, a specialty medication, with an ultimate completion date of November 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $6,103.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REPATHA 140 MG/ML SURECLICKML, a specialty medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $25,809.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the product "REPATHA 140 MG/ML SURECLICK", a specialty medication. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth $999,999,999 with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the pharmaceutical product REPATHA 140 MG/ML SURECLICKML. The $21,322.79 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024, with a completion date of June 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This federal contract award, valued at $4,777.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REPATHA 140 MG/ML SURECLICK, a specialty pharmaceutical product. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA87Q
    Delivery Order

This federal contract award by the Defense Logistics Agency (DLA) is for the procurement of REPATHA 140 MG/ML SURECLICKML, a specialty pharmaceutical product, from the prime contractor Amerisourcebergen Drug Corp. The award, valued at $2,103.96, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. The DLA IDC serves as a comprehensive vehicle for the government to procure a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. This specific contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, is registered in the System for Award Management (SAM.gov) and has a significant presence as a federal contractor, maintaining additional IDCs with other agencies such as the Department of Justice Federal Bureau of Investigation.

Generated 4/27/25, 12:58 AM